The Journal of Minimally Invasive Gynecology
Volume 16, Issue 1 , Pages 40-46 , January 2009

Rate, Type, and Cost of Invasive Interventions for Uterine Myomas in Germany, France, and England

  • Herve Fernandez, MD

      Affiliations

    • University Paris-Sud, Clamart, France
    • ,
  • Martin Farrugia, MD, MRCOG

      Affiliations

    • East Kent Hospitals National Health Service Trust, London, United Kingdom
    • ,
  • Siân E. Jones, FRCOG

      Affiliations

    • Bradford Teaching Hospitals National Health Service Foundation Trust, Bradford, West Yorkshire, United Kingdom
    • ,
  • Josephine A. Mauskopf, PhD

      Affiliations

    • RTI Health Solutions, RTI International, Durham, North Carolina
    • ,
  • Peter Oppelt, MD, MBA

      Affiliations

    • Frauenklinik Universitätsklinikum Erlangen, Germany
    • ,
  • Dhinagar Subramanian, MD, MBA

      Affiliations

    • European Health Economics, Ethicon, Livingston, United Kingdom
    • Corresponding Author InformationCorresponding author: Dhinagar Subramanian, MD, MBA, European Health Economics, Ethicon, Livingston EH54 7AT, United Kingdom.

Received 15 May 2008 ,Accepted 6 September 2008.

References 

  1. Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma on black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–107
  2. Marino JL, Eskenazi B, Warner M, et al. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod. 2004;19:2350–2355
  3. Pron G, Cohen M, Soucie J, et al. The Ontario uterine fibroid embolization trial, part 1: baseline patient characteristics, fibroid burden, and impact on life. Fertil Steril. 2003;79:112–119
  4. Pron G, Bennett J, Common A, et al. The Ontario uterine fibroid embolization trial, part 2: uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril. 2003;79:120–127
  5. Carlson KJ, Miller BA, Fowler FJ. The Maine women's health study, II: outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol. 1994;83:566–572
  6. Farquhar CM, Steiner CA. Hysterectomy rates in the United States 1990–1997. Obstet Gynecol. 2002;99:229–234
  7. Keshavarv H, Hillis SD, Kieke BA, et al. Hysterectomy surveillance–United States, 1994–1999. MMMWR Morb Mortal Wkly Rep. 2002;51:1–8
  8. HCUPnet query page. Agency for Healthcare Research and Quality. Available from: URL:http://hcupnet.ahrq.gov/. Accessed April 4, 2008.
  9. David-Montefiore E, Rouzier R, Chapron C, et al. Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals. Hum Reprod. 2007;22:260–265
  10. Vessey MP, Villard-Mackintosh L, McPherson K, et al. The epidemiology of hysterectomy: findings in a large cohort study. Br J Obstet Gynaecol. 1992;99:402–407
  11. Taylor A, Sharma M, Tsirkas P, et al. Surgical and radiological management of uterine fibroids–a UK survey of current consultant practices. Acta Obstet Gynecol Scand. 2005;84:478–482
  12. Flynn M, Jamison M, Datta S, et al. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195:955–964
  13. Wu O, Briggs A, Dutton S, et al. Uterine artery embolization or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study. BJOG. 2007;114:1352–1362
  14. Sculpher M, Manca A, Abbott J, et al. Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomized trial. BMJ. 2004;328:134
  15. Pourrat XJ, Fourquet F, Guerif F, et al. Medico-economic approach to the management of uterine myomas: a 6-month cost-effectiveness study of pelvic embolization versus vaginal hysterectomy. Eur J Obstet Gynecol Reprod Biol. 2003;111:59–64
  16. Cravello L, Isnardi M, Violin G, et al. Evaluation of direct hospital and extra-hospital cost of operative hysteroscopy and vaginal hysterectomy. J Gynecol Obstet Biol Reprod (Paris). 1999;28:335–342
  17. Institut für das Entgeltsystem im Krankenhaus gGmbH. G-DRG V2006 Browser § 21 KHEntgG. 2007. Available from: URL: http://www.g-drg.de/gdrgSystem2007/nutzung_p21b.php?v=2007. Accessed March 26, 2008.
  18. L'agence Technique de L'information sur L'hospitalisation. Statistiques par GHM Année: 2005. 2006. Available from: URL: http://www.atih.sante.fr/. Accessed April 4, 2008.
  19. HES online. The 2005 Hospital Episode Statistics database. 2008. Available from: URL:http://www.hesonline.nhs.uk/. Accessed April 4, 2008.
  20. United Nations Economic Commission for Europe. United Nations Economic Commission for Europe Population Statistics. 2007. Available from: URL: http://w3.unece.org/pxweb/DATABASE/STAT/30-GE/01-Pop/01-Pop.asp. Accessed April 4, 2008.
  21. Office of National Statistics. T 04: England; estimated resident population by single year of age and sex; mid-2005 population estimates. 2007. Available from: URL: http://www.statistics.gov.uk/statbase/ssdataset.asp?vlnk=9390&;More=Y. Accessed April 4, 2008.
  22. Secrétariat Général du Gouvernement . Arrêté du 27 février 2007 fixant pour l'année 2007 les ressources d'assurance maladie des établissements de santé exerçant une activité de médecine, chirurgie, obstétrique et odontologie. Journal Officiel De La République Française. 2005;Texte 17 sur 78
  23. L'agence Technique de L'information sur L'hospitalisation. Version 9 de la classification des GHM. 2004. Available from: URL: http://www.atih.sante.fr/index.php?id=0002500002FF. Accessed April 4, 2008.
  24. Department of Health. National Tariff 2005-06. 2004. Available from: URL: http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4091529. Accessed March 26, 2008.
  25. Secrétariat Général du Gouvernement . Décision du 18 juillet 2005 de l'Union nationale des caisses d'assurance maladie relative à la liste des actes et prestations pris en charge ou remboursés par l'assurance maladie. Journal Officiel De La République Française. 2005;Texte 4 sur 70
  26. Statistical Office of the European Communities. The Eurostat database. Available from: URL: http://epp.eurostat.ec.europa.eu. Accessed April 4, 2008.
  27. Arveux P, Bénard S, Bouée S, et al. Invasive cervical cancer treatment costs in France. Bull Cancer. 2007;94:219–224
  28. Brown RE, Breugelmans JG, Theodoratou D, et al. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Curr Med Res Opin. 2006;22:663–670
  29. Beinfeld MT, Bosch JL, Isaacson KB, et al. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology. 2004;230:207–213

 Funding for this study was provided by Ethicon. Drs. Fernandez and Farrugia act as paid consultants for Ethicon Women's Health and Urology. Drs. Jones and Oppelt are investigators in the Doppler-guided Uterine Artery Occlusion Study sponsored by Ethicon. They hold no stock in the company and have no financial interest in any of the company's products. Dr. Mauskopf has acted as a paid consultant for Johnson & Johnson and for many other pharmaceutical and medical device companies. She worked with Ethicon under a contract to prepare this manuscript. She holds no stock in any of the companies and has no financial interest in their products. Dr. Subramanian currently is an employee of Ethicon.

PII: S1553-4650(08)00977-1

doi: 10.1016/j.jmig.2008.09.581

The Journal of Minimally Invasive Gynecology
Volume 16, Issue 1 , Pages 40-46 , January 2009

Article Tools